- Home
- COGT vs PSNY Comparison
COGT vs PSNY Comparison
Compare COGT & PSNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- PSNY
- Stock Information
- Founded
- COGT 2014
- PSNY 2017
- Country
- COGT United States
- PSNY Sweden
- Employees
- COGT N/A
- PSNY N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- PSNY Auto Manufacturing
- Sector
- COGT Health Care
- PSNY Consumer Discretionary
- Exchange
- COGT Nasdaq
- PSNY Nasdaq
- Market Cap
- COGT 2.3B
- PSNY 1.9B
- IPO Year
- COGT 2018
- PSNY N/A
- Fundamental
- Price
- COGT $16.21
- PSNY $0.86
- Analyst Decision
- COGT Strong Buy
- PSNY Hold
- Analyst Count
- COGT 12
- PSNY 2
- Target Price
- COGT $22.00
- PSNY $1.25
- AVG Volume (30 Days)
- COGT 2.4M
- PSNY 3.3M
- Earning Date
- COGT 10-31-2025
- PSNY 09-03-2025
- Dividend Yield
- COGT N/A
- PSNY N/A
- EPS Growth
- COGT N/A
- PSNY N/A
- EPS
- COGT N/A
- PSNY N/A
- Revenue
- COGT N/A
- PSNY $2,547,619,000.00
- Revenue This Year
- COGT N/A
- PSNY $82.42
- Revenue Next Year
- COGT N/A
- PSNY $47.97
- P/E Ratio
- COGT N/A
- PSNY N/A
- Revenue Growth
- COGT N/A
- PSNY 24.82
- 52 Week Low
- COGT $3.72
- PSNY $0.82
- 52 Week High
- COGT $17.15
- PSNY $1.42
- Technical
- Relative Strength Index (RSI)
- COGT 60.52
- PSNY 39.16
- Support Level
- COGT $14.20
- PSNY $0.83
- Resistance Level
- COGT $16.42
- PSNY $0.90
- Average True Range (ATR)
- COGT 0.83
- PSNY 0.03
- MACD
- COGT -0.10
- PSNY 0.00
- Stochastic Oscillator
- COGT 67.97
- PSNY 27.52
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
About PSNY Polestar Automotive Holding UK PLC ADS
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.